Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a common blood pressure drug improve heart symptoms? new study investigates

NCT ID NCT06808321

Disease control Sponsor: The Society of Prevention and Awareness of Cardiovascular Diseases Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study will follow 800 adults in Turkey with high blood pressure or chronic chest pain (angina) who are already taking benidipine. Researchers will track how well the drug controls blood pressure and eases chest pain symptoms over time. The goal is to see how benidipine works in everyday medical practice.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Benidipine (a calcium channel blocker for blood pressure and chest pain)
What this could lead to
If successful, this could confirm benidipine as an effective option for managing high blood pressure and angina in a real-world Turkish population.
What could go wrong
This is an observational study, not a controlled trial, so results may be influenced by other factors. It only includes patients already on benidipine, which may bias outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 800 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2025

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients presenting to cardiology outpatient clinics in Turkey with hypertension and/or angina pectoris (chronic coronary syndrome)

Ages

18 to 80 years

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with hypertension and/or angina pectoris on the background of chronic coronary syndrome who have been receiving Benidipine treatment for at least 1 month and will continue to receive Benidipine treatment * Male or female outpatients, 18-80 years of age * Patients with mild to moderate essential hypertension who have been receiving or will continue Benidipine treatment for at least 1 month * Outpatients with clinically stable angina pectoris and patients who have been receiving or will continue Benidipine treatment for at least 1 month * Those who signed the written informed consent form Exclusion Criteria: * Patients with secondary hypertension * Emergency hypertensive patients * Having to take other medications during the study that may affect blood pressure * Allergic to DHP calcium antagonists * Evidence of decompensated congestive heart failure, unstable angina or severe arrhythmia * Severe renal or hepatic dysfunction * Pregnant or lactating women * Participation in other clinical trials within 3 months prior to this study * Patients who did not sign the consent form of the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Angina pectoris are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Angina Pectoris coronary artery disorder hypertensive disorder intermediate coronary syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Angina pectoris Chronic coronary syndrome Hypertension

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Antalya Kepez State Hospital

    Antalya, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.